Nordea Investment Management AB Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Nordea Investment Management AB raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 91,496 shares of the healthcare conglomerate’s stock after purchasing an additional 3,720 shares during the quarter. Nordea Investment Management AB’s holdings in UnitedHealth Group were worth $30,287,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Sagard Holdings Management Inc. acquired a new position in UnitedHealth Group in the 2nd quarter valued at $29,000. Foster Dykema Cabot & Partners LLC boosted its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 34 shares in the last quarter. 1248 Management LLC purchased a new position in UnitedHealth Group during the third quarter worth about $29,000. Holos Integrated Wealth LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $29,000. Finally, Hurley Capital LLC increased its position in UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of analyst reports. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Royal Bank Of Canada reduced their target price on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Leerink Partners cut their price target on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Finally, Jefferies Financial Group dropped their target price on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $272.30 on Wednesday. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The company’s 50-day moving average price is $294.53 and its 200 day moving average price is $323.80. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The stock has a market cap of $247.16 billion, a price-to-earnings ratio of 20.64, a PEG ratio of 1.24 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same period in the prior year, the business earned $6.81 earnings per share. The company’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is 67.02%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Company reiterates growth/efficiency push and is expanding AI investments to drive operational savings and revenue growth; management reiterated guidance at recent investor conference, which supports a constructive medium‑term outlook. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
• Positive Sentiment: Some analysts and commentators argue recent sell‑off is overdone and UnitedHealth’s diversified model and steady execution make current levels a buying opportunity for long‑term investors. UnitedHealth Group: Fears Remain Overblown In A Panicky Market
• Neutral Sentiment: Several pieces summarize Wall Street analysts’ bullish aggregate ratings (Average Brokerage Recommendation), noting analysts remain generally positive — useful context but may have limited short‑term impact given past optimism in sell‑side ratings. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Additional market commentary compares UNH’s steady profile to peers (Centene) and flags relative valuation and yield vs. growth tradeoffs — background analysis for positioning, not an immediate catalyst. The Upside Debate: UnitedHealth’s Consistency vs Centene’s Comeback
• Negative Sentiment: DOJ has escalated an antitrust probe into the relationship between Optum and UnitedHealth’s insurance arm, increasing regulatory risk and headline volatility that can pressure valuation. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
• Negative Sentiment: CVS reached a proposed settlement with the FTC in a high‑profile insulin pricing suit, leaving UnitedHealth (as a PBM/insurer market participant) as a potential remaining defendant/holdout — another legal/regulatory overhang. CVS, FTC reach proposed settlement in insulin pricing case
• Negative Sentiment: Several outlets note analyst downgrades and a pessimistic Zacks earnings estimate; pressure from widening gaps between reimbursement rates and medical expenses is cited as a near‑term profit margin risk. UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges UnitedHealth Stock Is Down 18% in 2026 and Keeps Stumbling Zacks Research Issues Pessimistic Estimate for UNH Earnings

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.